CAS: 677331-12-3
Ref: IN-DA00FC01
| 5mg | 100.00 € | ||
| 10mg | 122.00 € | ||
| 25mg | 188.00 € | ||
| 50mg | 228.00 € |
Estimated delivery in United States, on Thursday 12 Dec 2024
Ref: 4Z-I-113001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 19 Dec 2024
iCRT 14
CAS:677331-12-3
iCRT 14 is a novel potent inhibitor of β-catenin-responsive transcription (CRT)(IC50= 40.3 nM in assays …
Formula:
C21H17N3O2S
Purity:
98.85% - 99.8%
Color and Shape:
Solid
Molecular weight:
375.44
Ref: TM-T4486
| 2mg | 35.00 € | ||
| 5mg | 52.00 € | ||
| 10mg | 79.00 € | ||
| 25mg | 118.00 € | ||
| 50mg | 184.00 € | ||
| 100mg | 345.00 € | ||
| 1mL*10mM (DMSO) | 58.00 € |
Estimated delivery in United States, on Thursday 19 Dec 2024
iCRT-14
Controlled ProductCAS:677331-12-3
Applications A potent inhibitor of β-catenin-responsive transcription (CRT) (IC50 = 40.3 nM in assays of …
Formula:
C21H17N3O2S
Color and Shape:
Neat
Molecular weight:
375.44
Ref: TR-I163900
| 10mg | 244.00 € | ||
| 100mg | 1,632.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
iCRT-14
CAS:677331-12-3
iCRT-14 is a drug that has been shown to be effective in the treatment of …
Formula:
C21H17N3O2S
Purity:
Min. 95%
Molecular weight:
375.44 g/mol
Ref: 3D-FI24534
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 23 Jan 2025
